Stocks retreated last week on rising COVID-19 infections and slow progress on an economic relief bill. Click here to read the full article.

Stocks marched higher last week on an improving outlook for the passage of a fiscal stimulus plan. Click here to read the full article.

Stocks surged last week, ignited by another COVID-19 vaccine announcement, encouraging economic data, and the easing of political uncertainty. Click here to read the full article.

Despite news of another COVID-19 vaccine candidate, stocks were mixed amid investor anxiety over an increase in new infections and economic lockdowns. Click here to read the full article.

News of a COVID-19 vaccine ignited a rally in economically sensitive stocks and a broad retreat in technology companies last week, though enthusiasm was tempered by reports of rising new infections and fresh lock-downs. Click here to read the full article.

Stocks soared last week as investors anticipated that a split Congress would raise legislative hurdles to changing corporate taxes and adjusting regulatory oversight of big technology companies. Click here to read more.